Laurion Capital Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-164,258
| Closed | -$471K | – | 573 |
|
|
2024
Q1 | $471K | Buy |
+164,258
| New | +$471K | ﹤0.01% | 256 |
|
|
2023
Q3 | – | Sell |
-1,171,832
| Closed | -$775K | – | 428 |
|
|
2023
Q2 | $775K | Sell |
1,171,832
-120,768
| -9% | -$79.8K | ﹤0.01% | 164 |
|
|
2023
Q1 | $1.03M | Hold |
1,292,600
| – | – | 0.01% | 127 |
|
|
2022
Q4 | $2.92M | Buy |
1,292,600
+850,000
| +192% | +$1.92M | 0.01% | 97 |
|
|
2022
Q3 | $854K | Hold |
442,600
| – | – | 0.01% | 168 |
|
|
2022
Q2 | $1.65M | Buy |
+442,600
| New | +$1.65M | 0.03% | 130 |
|